10.08.2013 Views

Het volume van chirurgische ingrepen en de impact ervan op ... - KCE

Het volume van chirurgische ingrepen en de impact ervan op ... - KCE

Het volume van chirurgische ingrepen en de impact ervan op ... - KCE

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

74 Volume Outcome <strong>KCE</strong> reports 113<br />

RELATION BETWEEN HOSPITAL VOLUME AND 2-YEAR MORTALITY<br />

RATE<br />

Table 5.27 shows the results analyses which were performed with the international cut<br />

29, 126<br />

off of 11 procedures per year (AHRQ and Leapfrog threshold).<br />

Table 5.27: Pancreatic cancer surgery: mortality per hospital based on<br />

international <strong>volume</strong> thresholds<br />

International cut<br />

off<br />

AHRQ cut<br />

off<br />

Hospital<br />

<strong>volume</strong><br />

category<br />

Number<br />

c<strong>en</strong>tres<br />

Number<br />

pati<strong>en</strong>ts<br />

3-months<br />

mortality<br />

Number<br />

<strong>de</strong>aths<br />

2-year<br />

mortality<br />

% Number<br />

<strong>de</strong>aths<br />

11/year 1-10/year 68 187 23 12.3 105 56.1<br />

≥11/year 5 114 11 9.6 55 48.2<br />

Table 5.28 shows results from the logistic regression mo<strong>de</strong>l (with GEE to adjust for<br />

clustering of pati<strong>en</strong>ts within hospitals) used to examine the relation betwe<strong>en</strong> hospital<br />

<strong>volume</strong> and 2-year mortality following peripancreatic cancer surgery.<br />

The first mo<strong>de</strong>l was performed without adjustm<strong>en</strong>t for case mix and suggest that the<br />

odd of 2 year mortality is 30% higher in hospitals with less than 11 interv<strong>en</strong>tions per<br />

year than in hospital with at least 11 interv<strong>en</strong>tions per year: odds ratio and 95% CI: 1.31<br />

(0.71, 2.42) This result did not reach statistical significance.<br />

In the second mo<strong>de</strong>l, an adjustm<strong>en</strong>t was ma<strong>de</strong> for pati<strong>en</strong>t characteristics which were<br />

retrieved from the MCD data i.e. sex, age, principal diagnosis and Charlson score. This<br />

adjustm<strong>en</strong>t does not affect the results of the <strong>volume</strong> effect (odss ratio and 95% CI 1.29<br />

(0.85, 1.94)) Pati<strong>en</strong>ts with a duod<strong>en</strong>um tumour have a higher mortality than those with<br />

a pancreas tumour, although not statistically significant (OR = 1.23, 95%CI 0.40-3.79).<br />

Pati<strong>en</strong>ts with a malignant ne<strong>op</strong>lasm of extrahepatic bile ducts or ampulla of Vater have a<br />

significant better survival rate than those with a malignant ne<strong>op</strong>lasm of pancreas (OR =<br />

0.37, 95%CI 0.20-0.69).<br />

The third mo<strong>de</strong>l also adjusted for tumour characteristics such as stage and histology of<br />

the peripancreatic cancer. This adjustm<strong>en</strong>t barely affects the effect of <strong>volume</strong>: OD and<br />

95% CI 1.25 (0.83, 1.89).<br />

%

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!